Stocks and Investing Stocks and Investing
Mon, January 29, 2024
[ 12:00 AM ] - WOPRAI
Steven Alexopoulos Maintained (VLY) at Hold with Decreased Target to $12 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Nathan Jones Maintained (BMI) at Hold with Increased Target to $147 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Rafe Jasrosich Upgraded (BLDR) to Strong Buy on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Steven Shaw Maintained (BKU) at Hold with Increased Target to $28 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Benjamin Gerlinger Maintained (BKU) at Hold with Decreased Target to $33 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Jon Arfstrom Reiterated (BKU) at Hold and Held Target at $33 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
David Chiaverini Maintained (BKU) at Hold with Decreased Target to $31 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Sam Margolin Downgraded (BKR) to Hold on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Steven Cahall Downgraded (WBD) to Hold and Decreased Target to $12 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Ben Gerlinger Maintained (WAL) at Strong Buy with Increased Target to $82 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Jon Arfstrom Maintained (WAL) at Buy with Increased Target to $78 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Toshiya Hari Maintained (WDC) at Hold with Increased Target to $58 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Frank Schiraldi Maintained (WSFS) at Hold with Increased Target to $45 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Balaji Prasad Upgraded (ALVO) to Buy and Increased Target to $17 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (ALV) at Hold with Increased Target to $107 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Jeffrey Zekauskas Initiated (ALTM) at Hold and Held Target at $5 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Colin Bristow Maintained (AMGN) at Hold with Decreased Target to $314 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Christopher Rolland Maintained (AMD) at Buy with Increased Target to $210 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Vivek Arya Maintained (AMD) at Strong Buy with Increased Target to $195 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Joseph Moore Maintained (AMD) at Buy with Increased Target to $193 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
C J Muse Reiterated (AMD) at Buy and Held Target at $190 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
David Deckelbaum Downgraded (ALB) to Hold and Held Target at $130 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Whit Mayo Maintained (AHCO) at Strong Buy with Decreased Target to $9 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Louie DiPalma Initiated (AIR) at Buy on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Mark Devries Maintained (AXP) at Buy with Increased Target to $220 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (AXP) at Sell with Increased Target to $159 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Eric Wasserstrom Maintained (AXP) at Hold with Increased Target to $206 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Dominick Gabriele Maintained (AXP) at Buy with Increased Target to $219 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Jon Arfstrom Maintained (AXP) at Buy with Increased Target to $226 on, Jan 29th, 2024
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $47 on, Jan 29th, 2024

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $47 on, Jan 29th, 2024


Published on 2024-10-28 08:37:07 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $22 to $47 on, Jan 29th, 2024.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram

  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Monday, January 22nd, 2024
  • David Lebowitz of "Citigroup" Initiated at Strong Buy and Held Target at $42 on, Tuesday, November 7th, 2023
Contributing Sources